119 related articles for article (PubMed ID: 25592121)
1. Unintentional secondary exogenous corticosteroid exposure and central serous chorioretinopathy.
Thinda S; Lam K; Park SS
Eye (Lond); 2015 Apr; 29(4):577-9. PubMed ID: 25592121
[TBL] [Abstract][Full Text] [Related]
2. Associations Between Topical Ophthalmic Corticosteroids and Central Serous Chorioretinopathy: A Taiwanese Population-Based Study.
Chang YS; Weng SF; Chang C; Wang JJ; Wang JY; Jan RL
Invest Ophthalmol Vis Sci; 2015 Jun; 56(6):4083-9. PubMed ID: 26114485
[TBL] [Abstract][Full Text] [Related]
3. Central serous chorioretinopathy, corticosteroids, and uveitis.
Khairallah M; Kahloun R; Tugal-Tutkun I
Ocul Immunol Inflamm; 2012 Apr; 20(2):76-85. PubMed ID: 22409559
[TBL] [Abstract][Full Text] [Related]
4. Central serous chorioretinopathy in patients receiving exogenous testosterone therapy.
Nudleman E; Witmer MT; Kiss S; Williams GA; Wolfe JD
Retina; 2014 Oct; 34(10):2128-32. PubMed ID: 24946102
[TBL] [Abstract][Full Text] [Related]
5. Central serous chorioretinopathy secondary to corticosteroids in patients with atopic disease.
Ricketti PA; Unkle DW; Cleri DJ; Prenner JL; Coluccielo M; Ricketti AJ
Allergy Asthma Proc; 2015; 36(2):123-9. PubMed ID: 25715240
[TBL] [Abstract][Full Text] [Related]
6. A 30-Year-Old Man with a Recent History of COVID-19 Requiring Treatment with Corticosteroids Who Developed Bilateral Central Serous Chorioretinopathy During 7-Month Follow-Up.
Angelidis CD; Georgalas I; Giachos I; Symeonidis C; Mani A; Rotsos T
Am J Case Rep; 2023 Nov; 24():e940241. PubMed ID: 38007612
[TBL] [Abstract][Full Text] [Related]
7. Risk of central serous chorioretinopathy in adults prescribed oral corticosteroids: a population-based study in Taiwan.
Tsai DC; Chen SJ; Huang CC; Chou P; Chung CM; Chan WL; Huang PH; Lin SJ; Chen JW; Chen TJ; Leu HB
Retina; 2014 Sep; 34(9):1867-74. PubMed ID: 24743638
[TBL] [Abstract][Full Text] [Related]
8. Bilateral central serous chorioretinopathy caused by intranasal corticosteroids: a case report and review of the literature.
Kleinberger AJ; Patel C; Lieberman RM; Malkin BD
Laryngoscope; 2011 Sep; 121(9):2034-7. PubMed ID: 22024860
[TBL] [Abstract][Full Text] [Related]
9. Temporal Association between Topical Ophthalmic Corticosteroid and the Risk of Central Serous Chorioretinopathy.
Chang YS; Weng SF; Wang JJ; Jan RL
Int J Environ Res Public Health; 2020 Dec; 17(24):. PubMed ID: 33348672
[TBL] [Abstract][Full Text] [Related]
10. Central serous chorioretinopathy following kidney transplantation.
Farzan K; Rezaei L; Ghanbari H; Dehghani A
Saudi J Kidney Dis Transpl; 2014 May; 25(3):615-20. PubMed ID: 24821161
[TBL] [Abstract][Full Text] [Related]
11. Central serous chorioretinopathy and systemic corticosteroids in rheumatic diseases: report of three cases.
Valls Pascual E; Martínez-Costa L; Santander F
BMC Musculoskelet Disord; 2015 Dec; 16():378. PubMed ID: 26638151
[TBL] [Abstract][Full Text] [Related]
12. Intranasal Corticosteroids and Central Serous Chorioretinopathy: A Report and Review of the Literature.
Nakatsuka AS; Khanamiri HN; Lam QN; El-Annan J
Hawaii J Med Public Health; 2019 May; 78(5):151-154. PubMed ID: 31049263
[TBL] [Abstract][Full Text] [Related]
13. Retro-mode Imaging for retinal pigment epithelium alterations in central serous chorioretinopathy.
Shin YU; Lee BR
Am J Ophthalmol; 2012 Jul; 154(1):155-163.e4. PubMed ID: 22503695
[TBL] [Abstract][Full Text] [Related]
14. Central serous chorioretinopathy associated with high-dose follistatin-344: a retrospective case series.
Dağ U; Çağlayan M; Öncül H; Alakuş MF
Int Ophthalmol; 2020 Nov; 40(11):3155-3161. PubMed ID: 32671599
[TBL] [Abstract][Full Text] [Related]
15. Central serous chorioretinopathy after nasal corticosteroids in the aviator.
Ben Salem S; Sithom A; Ben Dhia I; Khelifi T; Askri H; Ayed A
Tunis Med; 2016 Nov; 94(11):695. PubMed ID: 28994874
[No Abstract] [Full Text] [Related]
16. The dilemma of central serous retinopathy, a corticosteroid-induced complication, in patients with ocular inflammatory disease.
Gupta SR; Suhler EB; Rosenbaum JT
J Rheumatol; 2010 Sep; 37(9):1973-4. PubMed ID: 20810529
[No Abstract] [Full Text] [Related]
17. Central serous chorioretinopathy after nasal corticosteroids in the aviator.
Ben Salem S; Sithom A; Ben Dhia I; Khelifi T; Askri H; Ayed A
Tunis Med; 2016 Dec; 94(12):893. PubMed ID: 28994894
[No Abstract] [Full Text] [Related]
18. The adverse effects of corticosteroids in central serous chorioretinopathy.
De Nijs E; Brabant P; De Laey JJ
Bull Soc Belge Ophtalmol; 2003; (289):35-41. PubMed ID: 14619628
[TBL] [Abstract][Full Text] [Related]
19. Central serous chorioretinopathy associated with topical corticosteroids in a patient with psoriasis.
Ezra N; Taban M; Behroozan D
J Drugs Dermatol; 2011 Aug; 10(8):918-21. PubMed ID: 21818516
[TBL] [Abstract][Full Text] [Related]
20. Increased risk of erectile dysfunction among males with central serous chorioretinopathy -- a retrospective cohort study.
Tsai DC; Huang CC; Chen SJ; Chou P; Chung CM; Chan WL; Huang PH; Lin SJ; Chen JW; Leu HB
Acta Ophthalmol; 2013 Nov; 91(7):666-71. PubMed ID: 22998678
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]